1T-LSD: Difference between revisions

Edit links
Source: Wikipedia, the free encyclopedia.
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
Zwitfire (talk | contribs)
103 edits
mNo edit summary
Tag: Reverted
Line 6: Line 6:


<!--Clinical data-->| tradename =
<!--Clinical data-->| tradename =
| legal_AU = Unscheduled
| legal_AU =
| legal_CA = Unscheduled
| legal_CA =
| legal_DE = Unscheduled
| legal_DE =
| legal_UK = Unscheduled
| legal_UK =
| legal_US = Unscheduled
| legal_US =
| legal_US_comment = In general Legal
| legal_US_comment =
| routes_of_administration = [[Oral administration|By mouth]], [[Sublingual administration|under the tongue]] <!--Identifiers-->
| routes_of_administration = [[Oral administration|By mouth]], [[Sublingual administration|under the tongue]] <!--Identifiers-->
| CAS_number =
| CAS_number =

Revision as of 23:59, 9 February 2024

1T-LSD
Clinical data
Routes of
administration		By mouth, under the tongue
Identifiers
  • (6aR,9R)-N,N-diethyl-7-methyl-4-(thiophen-2-yl)methanoyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide
Chemical and physical data
JSmol)
  • O=C(n1cc2C[C@@H]3C(=C[C@H](CN3C)C(=O)N(CC)CC)c3cccc1c32)c1cccs1

1T-LSD (N1-(thiophene-2-carbonyl)-lysergic acid diethylamide) is an

lysergic acid diethylamide (LSD), which has been sold as a designer drug. It was first identified in Japan in 2023 on blotter paper misrepresented as containing 1D-LSD, but which on analysis was determined to contain 1T-LSD instead.[1]

See also

References

  1. S2CID 259374662
    .
Stub icon

This hallucinogen-related article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=1T-LSD&oldid=1205572949"